Measuring the electrical activity of muscles in the neck in ALS may be easier for some patients than using the tongue for such testing.

Exposure to rhodamine B (RhB), a toxic fluorescent dye, causes neurodegeneration, symptoms that resemble ALS, and molecular changes.

Inhibition of a cellular stress response may be a therapeutic target for ALS type 8 related to mutations in the VAPB gene, a study reports.

Thanks to a gift from her husband with ALS, columnist Kristin Neva takes a journey through joy and sorrow in years of photographed birthdays.

Being exposed to rhodamine B (RhB), a toxic fluorescent dye, causes neurodegeneration and symptoms that resemble amyotrophic lateral sclerosis (ALS) in zebrafish, a study reports.

Marisa Wexler is a senior science writer for ALS News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis ...

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

Answer ALS is backing a Louisiana collaboration aimed at using AI to accelerate drug discovery for ALS and other neurodegenerative disorders.

The ALS Association has announced the eight winners two new Hoffman award programs designed to improve access to multidisciplinary ALS care.

Columnist Kristin Neva shares what she feels has worked and not worked in terms of slowing her husband's ALS progression over 15 years.

Completing a project in her backyard was satisfying for columnist Kristin Neva, whose work as an ALS caregiver is repetitive and ongoing.

AUT00201, an experimental oral small molecule being developed by Autifony Therapeutics, reduced the loss of motor neurons — the nerve cells that control movement — and eased motor symptoms in a mouse ...